References
- LeeKYMooneyDJAlginate: properties and biomedical applicationsProg Polym Sci2012371 106 12622125349
- TønnesenHHKarlsenJAlginate in drug delivery systemsDrug Dev Ind Pharm2002286 621 63012149954
- SavarinoEPohlDZentilinPFunctional heartburn has more in common with functional dyspepsia than with non-erosive reflux diseaseGut2009589 1185 119119460766
- MirshafieyARehmBHAlginate and its comonomer mannuronic acid: medical relevance as drugsRehmBHAlginates: Biology and ApplicationsBerlin HeidelbergSpringer2009 229 260
- MirshafieyARehmBAbhariRSBorzooyZSotoudeMRazaviAProduction of M2000 (β-d-mannuronic acid) and its therapeutic effect on experimental nephritisEnviron Toxicol Pharmacol2007241 60 6621783790
- MirshafieyARehmBSotoudeMRazaviAAbhariRSBorzooyZTherapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritisImmunopharmacol Immunotoxicol2007291 49 6117464766
- MirshafieyACuzzocreaSRehmBMatsuoHM2000: a revolution in pharmacologyMed Sci Monit2005118 I53 I63
- MirshafieyAMatsuoHNakaneSRehmBHKohCSMiyoshiSNovel immunosuppressive therapy by M2000 in experimental multiple sclerosisImmunopharmacol Immunotoxicol2005272 255 26516114509
- MirshafieyACuzzocreaSRehmBMazzonESaadatFSotoudeMTreatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drugScand J Immunol2005615 435 44115882435
- MirshafieyAKhorramizadehMRSaadatFRehmBHAChemo-preventive effect of M2000, a new anti-inflammatory agentMed Sci Monit20041010 I105 I109
- FattahiMJAbdollahiMAgha MohammadiAPreclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drugImmunopharmacol Immunotoxicol2015376 535 54026584020
- ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum1988313 315 3243358796
- CopeASchulze-KoopsHAringerMThe central role of T cells in rheumatoid arthritisClin Exp Rheumatol2007255 S417977483
- SarkarSCooneyLFoxDAThe role of T helper type 17 cells in inflammatory arthritisClin Exp Rheumatol20101593 225 237
- OhmuraKNguyenLTLocksleyRMMathisDBenoistCInterleukin-4 can be a key positive regulator of inflammatory arthritisArthritis Rheum2005526 1866 187515934072
- GaffenSLThe role of interleukin-17 in the pathogenesis of rheumatoid arthritisCurr Rheumatol Rep2009115 365 37019772832
- SinghJAFurstDEBharatA2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care Res (Hoboken)2012645 625 63922473917
- GøtzschePCJohansenHKShort-term low-dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritisCochrane Library2005 1
- LaineLBombardierCHawkeyCJStratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritisGastroenterology20021234 1006 101212360461
- BinghamCOThe pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammationJ Rheumatol200265 3 9
- RicciottiEFitzGeraldGAProstaglandins and inflammationArterioscler Thromb Vasc Biol2011315 986 100021508345
- McInnesIBSchettGCytokines in the pathogenesis of rheumatoid arthritisNat Rev Immunol200776 429 44217525752
- McInnesIBSchettGThe pathogenesis of rheumatoid arthritisN Engl J Med201136523 2205 221922150039
- McKenzieGJFallonPGEmsonCLGrencisRKMcKenzieANSimultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2–mediated responsesJ Exp Med199918910 1565 157210330435
- TesmerLALundySKSarkarSFoxDATh17 cells in human diseaseImmunol Rev20082231 87 11318613831
- MiossecPIL-17 and Th17 cells in human inflammatory diseasesMicrobes Infect2009115 625 63019371791
- Al-SaadanyHMHusseinMSGaberRAZaytounHATh-17 cells and serum IL-17 in rheumatoid arthritis patients: correlation with disease activity and severityEgypt Rheumatol2016381 1 7
- KoshyPHendersonNLoganCLifePFCawstonTERowanADInterleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokinesAnn Rheum Dis2002618 704 71312117676
- PetersTLMcClainKLAllenCENeither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesionsMol Ther2011198 1433 143921654633
- RatajewskiMWalczak-DrzewieckaASałkowskaADastychJUpstream stimulating factors regulate the expression of RORγT in human lymphocytesJ Immunol20121896 3034 304222891280
- KehrmannJTaturaRZeschnigkMImpact of 5-aza-2′-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cellsJ Immunol20141423 384 395
- ChiuYHChenHGATA3 inhibits GCM1 activity and trophoblast cell invasionSci Rep20166 2163026899996
- NathanCDingANonresolving inflammationCell20101406 871 88220303877
- SinghJAChristensenRWellsGABiologics for rheumatoid arthritis: an overview of Cochrane reviewsSao Paulo Med J20101285 309 31021181074
- LeeYHRhoYHChoiSJJiJDSongGGAssociation of TNF-alpha–308 G/A polymorphism with responsiveness to TNF-α-blockers in rheumatoid arthritis: a meta-analysisRheumatol Int2006272 157 16116909270
- DayRAdverse reactions to TNF-α inhibitors in rheumatoid arthritisLancet20023599306 540 54111867103